Clinical Trials Browser

Melanoma, Neoplasm Metastasis

NCT07455331 2026-05-11

LANCE

Phase 2 Not yet recruiting

60 enrolled

Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms

NCT07576725 2026-05-08

Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial

Phase 2 Not yet recruiting

50 enrolled

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidSarcomaThoracic

Clear-cell metastatic renal cell carcinoma, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Basal Cell, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Hodgkin Disease, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Sarcoma, Kaposi, Colorectal Neoplasms, Carcinoma, Merkel Cell

Clinical Trials

EPIBREAST

LANCE

Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial

INFLECTION-003

Fianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanoma

NeoMatryx

Neoadjuvant SHR-1701 Plus Famitinib With Response-guided Adjuvant Therapy in Resectable Mucosal Melanoma

A Phase 2 Study of HW211026 in Participants With Actinic Keratosis

PROSECCO: A Phase 2, Single Arm, Neoadjuvant Study Evaluating Combination Cemiplimab, Fianlimab, And Ipilimumab In Patients With Surgically Resectable Melanoma

TRIUMPH-AM

GAPIMET

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma

L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)

L19IL2/TNF in Patients With Basal Cell Carcinoma

HS-IT101 Injection Versus Chemotherapy in the Treatment of Advanced Melanoma

Testing the Effect of Sulforaphane, a Compound Naturally Found in Cruciferous Vegetables, on Preventing Melanoma in Patients With a Prior History of Melanoma

INTROSPECTION

PDT vs Peels for Treatment of Actinic Keratoses

Clinical Observation on the Safety and Efficacy of Cardonilmab in the Treatment of Second-line and Above Advanced Melanoma and Advanced Renal Cancer

TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid Tumors

DyNAMIc

Cadonilimab in Combination With Anlotinib in the Treatment of Locally Progressive or Metastatic Melanoma With First-Line Therapy Failure

CVL237 Tablets in the Treatment of Advanced Solid Tumors With PTEN Deficiency

PANDORA

Cytokine-induced Killer Study for Patients With Stage II Melanoma